ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent-Final Results from a Phase 2 StudyANNALS OF SURGICAL ONCOLOGYIF3.52024-05-090PRE
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II StudyANNALS OF SURGICAL ONCOLOGYIF3.52024-04-155PRE
MUC16 expression in pancreatic ductal adenocarcinoma patient samples after neoadjuvant chemotherapyCANCER RESEARCHIF16.62024-01-160PRE
Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastomaJOURNAL OF CONTROLLED RELEASEIF11.52020-11-019OAAI
Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic CancerMOLECULAR CANCER THERAPEUTICSIF5.52020-08-0416OAAI
Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast CancerMOLECULAR IMAGING AND BIOLOGYIF2.52019-12-0912OAAI
Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and TranslationMOLECULAR IMAGING AND BIOLOGYIF2.52018-06-2562OA